Chiome Bioscience Inc. (TYO:4583)
Japan · Delayed Price · Currency is JPY 107.00
-2.00 (-1.83%)
At close: Mar 6, 2026
Chiome Bioscience Market Cap
Chiome Bioscience has a market cap or net worth of 7.43 billion as of March 6, 2026. Its market cap has decreased by -56.99% in one year.
Market Cap
7.43B
Enterprise Value
6.31B
Revenue
593.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
107.00
Market Cap Chart
Since December 20, 2011, Chiome Bioscience's market cap has increased from 470.00M to 7.43B, an increase of 1,480.91%. That is a compound annual growth rate of 21.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.43B | 2.06% |
| Dec 30, 2025 | 7.28B | -58.55% |
| Dec 30, 2024 | 17.56B | 149.35% |
| Dec 29, 2023 | 7.04B | -18.27% |
| Dec 30, 2022 | 8.62B | 9.67% |
| Dec 30, 2021 | 7.86B | 6.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrightPath Biotherapeutics | 8.30B |
| MEDINET | 8.00B |
| ADR120S | 7.76B |
| CellSource | 7.57B |
| OncoTherapy Science | 7.53B |
| Linical | 7.00B |
| PRISM BioLab Co.,LTD | 6.69B |
| Carna Biosciences | 6.33B |